XML 100 R86.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION - SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 60.70 $ 47.11 $ 35.01  
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 380,819 305,269 195,305 138,896
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 76.76 $ 49.56 $ 54.64  
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Stock-settled appreciation rights granted 122,812 158,756 126,874  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 33.19 $ 13.86 $ 16.36  
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 916,906 391,339 113,099  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 13,854 46,245 115,103  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 54.42 $ 65.93 $ 65.27  
Weighted Average Remaining Contractual Term, Outstanding 6 years 1 month 6 days      
Weighted Average Remaining Contractual Term, Exercisable 5 years 3 months 18 days      
Aggregate Intrinsic Value, Outstanding $ 95,246      
Aggregate Intrinsic Value, Exercisable $ 68,920      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,001,708 1,630,891 1,723,370  
Stock-settled appreciation rights granted 139,592 262,091 213,618  
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $ 62.79 $ 62.72 $ 59.00  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 62.09 $ 60.48 $ 59.72 $ 59.26
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1,370,388 2,161,556 2,337,049 2,351,633
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 77.05 $ 48.32 $ 54.63